Lactobacillus salivarius for the treatment of mastitis
AssigneeN.V. Nutricia
InventorsRocio Martin, Jan Knol, Leonides Fernández Álvarez, Irene Espinosa Martos, Esther Antonia Jiménez Quintana, Juan Miguel Rodríguez Gómez
Life of this patent
Estimating the term…
Abstract
The invention relates to a new strain of Lactobacillus salivarius, products containing the new strain, the use thereof in and methods for the treatment and/or prevention of inflammation and/or infection in breast or udder tissue, particularly in a mammary gland of a human female. The inflammation and/or infection is preferably mastitis.
Claims10
A freeze-dried strain of Lactobacillus salivarius having accession number LMG P-27027.
A composition comprising a freeze-dried strain of Lactobacillus salivarius having accession number LMG P-27027 and a physiologically acceptable carrier or excipient.
A composition comprising 105 to 1011 cfu of freeze-dried Lactobacillus salivarius having accession number LMG P-27027 per gram dry weight of the composition, and a physiologically acceptable carrier or excipient.
A method of treatment of inflammation and/or infection of breast or udder tissue in a mammal, comprising administering to the mammal a composition comprising a freeze-dried strain of Lactobacillus salivarius having accession number LMG P-27027.
Dependencies are inferred from the claim text.